Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Panzer

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Klinische Padiatrie|November 29, 2014
Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trialA Attarbaschi, R Panzer-Grümayer, G Mann, et al.
Leukemia|February 12, 1999
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemiaM J Pongers-Willemse, T Seriu, F Stolz, et al.
Journal of Clinical Microbiology|May 3, 2014
Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumoniaG Singh, R Srinivasan, J Cheng, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|November 9, 2000
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study groupA Biondi, M G Valsecchi, T Seriu, et al.
Leukemia|March 10, 2015
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessmentC Eckert, N Hagedorn, L Sramkova, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 17, 2009
Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysisE Csinady, V H J van der Velden, R Joas, et al.
Leukemia Research|December 17, 2008
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemiaH von Goessel, U Jacobs, S Semper, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Klinische Padiatrie|November 29, 2014
Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trialA Attarbaschi, R Panzer-Grümayer, G Mann, et al.
Leukemia|February 12, 1999
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemiaM J Pongers-Willemse, T Seriu, F Stolz, et al.
Journal of Clinical Microbiology|May 3, 2014
Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumoniaG Singh, R Srinivasan, J Cheng, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|November 9, 2000
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study groupA Biondi, M G Valsecchi, T Seriu, et al.
Leukemia|March 10, 2015
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessmentC Eckert, N Hagedorn, L Sramkova, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 17, 2009
Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysisE Csinady, V H J van der Velden, R Joas, et al.
Leukemia Research|December 17, 2008
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemiaH von Goessel, U Jacobs, S Semper, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Pageof 8